ADVENZYMES.NS
Key Ratios

Net Profit Margin: Making high profit when compared with its revenue which generally means company’s strong hold in the market, and good efficiency of the business

Acid Test Ratio: It has very strong liquidity, which means it can can cover its liabilities without relying on inventory

Inventory Turnover: Very Slow Inventory movement or over stocking risk

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

P/E Ratio: A little overvalued stock but represent growth stock and possibility of future growth

Performance Graph
Financial Ratios
Ratio Value
PE Ratio28.89
Net Profit Margin0.21
Acid Test Ratio6.22
Inventory Turnover1.07
Coverage Ratio8.48
Debt to Equity0.04
Key Ratios

Net Profit Margin: Making high profit when compared with its revenue which generally means company’s strong hold in the market, and good efficiency of the business

Return on Assets: Very high efficiency of the assets which indicates assets are making high contribution to the revenue

Return on Equity: Giving good returns on equity which is generally acceptable for most industries

Performance Graph
Profitability Ratios
Ratio Value
Net Profit Margin0.21
Return on Assets0.77
Return on Equity0.10
Performance Graph
Key Ratios

Acid Test Ratio: It has very strong liquidity, which means it can can cover its liabilities without relying on inventory

Current Ratio: It has excess cash even after covering its short-term liabilities, which also may indicates mismanagement os assets in some cases

Performance Graph
Liquidity Ratios
Ratio Value
Acid Test Ratio6.22
Current Ratio7.61
Performance Graph
Key Ratios

Inventory Turnover: Very Slow Inventory movement or over stocking risk

Performance Graph
Efficiency Ratios
Ratio Value
Inventory Turnover1.07
Performance Graph
Key Ratios

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Performance Graph
Coverage Ratios
Ratio Value
Coverage Ratio8.48
Performance Graph
Key Ratios

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

Interest Coverage Ratio: Company is at low risk of getting default as it can easily cover its interest payments and strong financial health

Performance Graph
Solvency Ratios
Ratio Value
Debt to Equity Ratio0.04
Interest Coverage Ratio65.15
Performance Graph
Key Ratios

P/E Ratio: A little overvalued stock but represent growth stock and possibility of future growth

Dividend Yield: Low yield, focus on growth rather than dividends (Low dividend yield, which means company is focusing on growth

Performance Graph
Market Ratios
Ratio Value
P/E Ratio28.89
Gross Profit Margin0.74
Price to Book Ratio2.91
Dividend Yield0.00
Performance Graph

Balance Sheet Analysis of Advanced Enzyme Technologies Limited

The balance sheet in the financial statement of the company shows its financial position at a particular point in time.

It consists of the following:

  • Assets: Something that the company owns and that gives financial benefits over a period of time.
  • Liabilities: Something that a company owes and that has a financial burden on the company.
  • Equity: It is basically the owner’s share in the company.

The formula is:

Assets = Liabilities + Equity
đź“ŚAssets:
Asset
Value & Year
2024
2023
2022
Total Assets 15354630000 14218470000 12676090000
Total Non Current Assets 7259930000 7007910000 6672550000
Other Non Current Assets 300000 850000 840000
Non Current Prepaid Assets 80230000 62410000 81280000
Non Current Deferred Taxes Assets 142820000 113420000 74200000
Financial Assets - - -
Investment In Financial Assets 1710000 1700000 700000
Held To Maturity Securities - - -
Available For Sale Securities 60000 50000 50000
Financial Assets Fair Value 1650000 1650000 650000
Long Term Equity Investment - - -
Investments In Associates At Cost - - -
Goodwill And Other Intangible Assets 3835810000 3817310000 3623690000
Other Intangible Assets 582860000 608780000 663060000
Goodwill 3252950000 3208530000 2960630000
Net Ppe 3072660000 2888220000 2718080000
Accumulated Depreciation -1880840000 -1620480000 -1374110000
Gross Ppe 4953500000 4508700000 4092190000
Construction In Progress 307370000 156090000 96280000
Other Properties 2765280000 2732130000 2621800000
Machinery Furniture Equipment 2665830000 2500370000 2341960000
Buildings And Improvements 1399320000 1280500000 1123940000
Land And Improvements 580980000 571740000 530010000
Properties - - -
Current Assets 8094710000 7210560000 6003540000
Other Current Assets 17260000 9680000 4730000
Hedging Assets Current - - -
Assets Held For Sale Current - - -
Restricted Cash 2260000 5920000 44770000
Prepaid Assets 111040000 98160000 98970000
Inventory 1484550000 1239900000 1209200000
Other Inventories - - -
Finished Goods 357870000 286530000 347250000
Work In Process 363410000 325840000 303540000
Raw Materials 763270000 627530000 558410000
Other Receivables 14200000 10680000 26410000
Taxes Receivable - - -
Accounts Receivable 985680000 1003410000 882060000
Allowance For Doubtful Accounts Receivable -12360000 -15470000 -8480000
Gross Accounts Receivable 998040000 1018880000 890540000
Cash Cash Equivalents And Short Term Investments 5479720000 4842810000 3737400000
Other Short Term Investments 4342210000 3878610000 1063850000
Cash And Cash Equivalents 1137510000 964200000 2673550000
Cash Equivalents 717480000 363680000 819940000
Cash Financial 420030000 600520000 1853610000
đź“Ś Liabilities & Equity
Liability/Equity
Value & Year
2024
2023
2022
Net Debt - - -
Total Debt 473080000 334990000 347300000
Total Liabilities Net Minority Interest 1643830000 1376760000 1272230000
Total Non Current Liabilities Net Minority Interest 580260000 601100000 668010000
Other Non Current Liabilities - - -
Derivative Product Liabilities - - -
Non Current Pension And Other Postretirement Benefit Plans 8860000 5060000 10680000
Trade And Other Payables Non Current - - -
Non Current Deferred Revenue - - -
Non Current Deferred Taxes Liabilities 343240000 372270000 392500000
Long Term Debt And Capital Lease Obligation 228160000 223770000 264830000
Long Term Capital Lease Obligation 158560000 145780000 183530000
Long Term Debt 69600000 77990000 81300000
Long Term Provisions 8860000 5060000 10680000
Current Liabilities 1063570000 775660000 604220000
Other Current Liabilities 135910000 105220000 97750000
Current Deferred Taxes Liabilities - - -
Current Debt And Capital Lease Obligation 244920000 111220000 82470000
Current Capital Lease Obligation 63400000 56820000 54370000
Current Debt 181520000 54400000 28100000
Pension And Other Post Retirement Benefit Plans Current - - -
Current Provisions 196750000 37190000 38220000
Payables 524610000 550850000 414200000
Other Payable 274020000 292630000 232160000
Dividends Payable 1590000 1170000 1080000
Total Tax Payable 91410000 14840000 1990000
Accounts Payable 157590000 242210000 178970000
Common Stock Equity 13241280000 12350690000 10885930000
Total Capitalization 13310880000 12428680000 10967230000
Total Equity Gross Minority Interest 13710800000 12841710000 11403860000
Minority Interest 469520000 491020000 517930000
Stockholders Equity 13241280000 12350690000 10885930000
Other Equity Interest 30310000 12127040000 6400000
Treasury Stock - - -
Retained Earnings 10794910000 10022770000 9072970000
Additional Paid In Capital 821310000 821310000 813550000
Capital Stock 223650000 223650000 223600000
Common Stock 223650000 223650000 223600000

Income statement interpretation for Advanced Enzyme Technologies Limited

The income statement in the financial statement of the company shows its company financial performance over a period in time.

It consists of the following:

  • Revenue: It is the total amount of money earned from the core business activity of the company.
  • Expenses: It is the total amount required for running the full functionality of the company.
  • Profit or loss:In very simple terms, when a company pays its expenses using its revenue, then what’s left is profit, and in case expenses are more when compared with revenue, then it is loss.
đź“ŚRevenue & Profitability
Revenue/Profitability
Value & Year
2024
2023
2022
Total Revenue 6234770000 5403820000 5289040000
Operating Revenue 6234770000 5403820000 5289040000
Cost Of Revenue 1594110000 1427680000 1194300000
Gross Profit 4640660000 3976140000 4094740000
Ebitda 2259910000 1778380000 2078370000
Ebit 1907490000 1428090000 1728540000
Operating Income 1728280000 1382960000 1685650000
Net Income 1333050000 1056390000 1195820000
Net Income From Continuing Operation Net Minority Interest 1333050000 1056390000 1195820000
Net Income From Continuing And Discontinued Operation 1333050000 1056390000 1195820000
Net Income Common Stockholders 1333050000 1056390000 1195820000
Net Income Including Noncontrolling Interests 1369510000 1038660000 1237990000
Net Income Discontinuous Operations - - -
Net Income Continuous Operations 1369510000 1038660000 1237990000
Normalized Income 1398083514 1124123227 1194162669
Normalized Ebitda 2349100000 1869930000 2076080000
Total Unusual Items -89190000 -91550000 2290000
Total Unusual Items Excluding Goodwill -89190000 -91550000 2290000
đź“ŚExpenses & Taxes
Expenses/Taxes
Value & Year
2024
2023
2022
Reconciled Depreciation 352420000 350290000 349830000
Reconciled Cost Of Revenue 1594110000 1427680000 1194300000
Total Expenses 4506490000 4020860000 3603390000
Operating Expense 2912380000 2593180000 2409090000
Other Operating Expenses 793590000 752440000 618980000
Depreciation And Amortization In Income Statement 352420000 350290000 349830000
Amortization 77400000 73040000 79980000
Depreciation Income Statement 275020000 277250000 269850000
Selling General And Administration 397220000 379080000 354850000
Selling And Marketing Expense 156510000 160820000 147660000
General And Administrative Expense 240710000 218260000 207190000
Rent And Landing Fees 79530000 62360000 42380000
Tax Provision 508700000 365220000 472590000
Pretax Income 1878210000 1403880000 1710580000
Other Non Operating Income Expenses 141580000 39400000 45690000
Special Income Charges -175320000 -64310000 2290000
Other Special Charges 154370000 48130000 -11500000
Write Off 20950000 9310000 9210000
Net Non Operating Interest Income Expense 92050000 60050000 -25510000
Total Other Finance Cost 11930000 10570000 11590000
Interest Expense Non Operating 29280000 24210000 17960000
Interest Income Non Operating 133260000 94830000 4040000
đź“Ś Earnings Per Share
Earnings Per Share
Value & Year
2024
2023
2022
Diluted Eps 11.92 9.45 10.68
Basic Eps 11.92 9.45 10.70
Diluted Ni Avail To Com Stockholders 1333050000 1056390000 1195820000
Net Income From Continuing Operations 1878210000 1403880000 1710580000
Minority Interests -36460000 17730000 -42170000

Cash flow analysis for Advanced Enzyme Technologies Limited

The cashflow statement in the financial statement of the company shows how cash is moving in or moving out of the company over a period of time.

It consists of the following:

  • Operating activities: Cash flow from the core business operations.
  • Investing activities: Cashflow from investments made by the company.
  • Financing activities: These are cash from loans or by issuing shares or paying out dividends.
đź“ŚOperating Cash Flow
Operating Cash Flow
Value & Year
2024
2023
2022
Operating Cash Flow 1413690000 1403620000 1222910000
Changes In Cash 174820000 -1836170000 700040000
Taxes Refund Paid -492340000 -366390000 -545310000
Change In Working Capital -262530000 -3410000 -273990000
Change In Other Current Liabilities -1280000 22860000 -28300000
Change In Other Current Assets -31440000 15460000 6680000
Change In Payable -39410000 60280000 27980000
Change In Inventory -238340000 7550000 -260950000
Change In Receivables 7730000 -101340000 -14030000
Other Non Cash Items -100260000 -21140000 7200000
Stock Based Compensation 30310000 - -
Provision And Write Off Of Assets 105700000 4200000 -9930000
Depreciation And Amortization 352420000 350290000 349830000
Amortization Cash Flow 77400000 73040000 79980000
Depreciation 275020000 277250000 269850000
đź“ŚInvesting Cash Flow
Investing Cash Flow
Value & Year
2024
2023
2022
Investing Cash Flow -646490000 -2981810000 -37870000
Net Other Investing Changes - 500000 -
Interest Received Cfi 129390000 78700000 12280000
Dividends Received Cfi - - -
Net Investment Purchase And Sale -304300000 -2681740000 218600000
Sale Of Investment - - 220990000
Purchase Of Investment -304300000 -2681740000 -2390000
Net Business Purchase And Sale - - -
Sale Of Business - - -
Purchase Of Business - - -
Net Ppe Purchase And Sale -421580000 -378510000 -268150000
Sale Of Ppe 1550000 2540000 13010000
Purchase Of Ppe -423130000 -381050000 -281160000
Net Intangibles Purchase And Sale -500000 -760000 -600000
Purchase Of Intangibles -500000 -760000 -600000
đź“Ś Financing Cash Flow
Financing Cash Flow
Value & Year
2024
2023
2022
Financing Cash Flow -592380000 -257980000 -485000000
Net Other Financing Charges -56070000 -68000000 -211250000
Interest Paid Cff -29250000 -24210000 -17760000
Cash Dividends Paid -567120000 -125420000 -118600000
Common Stock Dividend Paid -567120000 -125420000 -118600000
Net Common Stock Issuance - 1420000 4340000
Common Stock Payments - - -
Common Stock Issuance - 1420000 4340000
Repurchase Of Capital Stock - - -
Repayment Of Debt -6480000 -3220000 -23200000
Issuance Of Debt 127030000 26220000 6740000
Issuance Of Capital Stock - 1420000 4340000
Net Issuance Payments Of Debt 120550000 23000000 -81380000
Net Short Term Debt Issuance 127030000 26220000 -64920000
Short Term Debt Issuance 127030000 26220000 -
Net Long Term Debt Issuance -6480000 -3220000 -16460000
Long Term Debt Payments -6480000 -3220000 -23200000
Long Term Debt Issuance - - 6740000
Net Preferred Stock Issuance - - -
Preferred Stock Payments - - -

Summary

Fundamental Overview of ADVENZYMES.NS (Advanced Enzyme Technologies Limited)

Above is the summary for fundamental analysis of Advanced Enzyme Technologies Limited , whose ticker name is ADVENZYMES.NS and belongs to sector Basic Materials, and it is listed in NSE (National Stock Exchange).

The Advanced Enzyme Technologies Limited which is listed in NSE (National Stock Exchange) has a PE ratio of 28.89, ADVENZYMES.NS has a net profit margin of 0.21, the acid test ratio for ADVENZYMES.NS is 6.22, ADVENZYMES.NS has an inventory turnover of 1.07, and ADVENZYMES.NS has debt-to-equity ratio of 0.04.

The ADVENZYMES.NS whose company name is Advanced Enzyme Technologies Limited has made profit/loss of 4640660000 with total revenue of 6234770000, ADVENZYMES.NS has assets worth of 15354630000.

1. What is fundamental analysis?

Fundamental analysis is looking into a company’s real business performance by analyzing financial statements, earning reports, and key valuation ratios.

Basically, fundamental analysis involves examining a company’s revenue, profits, losses, debts, assets, liabilities, and ratios calculated using these values to determine long-term investment strategies.

Fundamental analysis may not work for short-term trading of stock; it is usually incorporated by long-term investors.

2. Importance of Fundamental Analysis

Imagine you are locking a good amount of funds into an unknown company for many years. Sounds stupid, right?

This is where fundamental analysis comes into the picture, which turns an unknown enemy into a known friend.

As fundamental analysis involves calculating how a company is actually performing, the real revenue, profits, assets, liabilities, debts, and more. This helps investors to determine what the actual current financial condition of the company is, how much the company’s stock price is justified when compared to earnings (Corporate earnings reports India) that it is making through business, what the probability is that the company will go bankrupt in the future, how much growth the company has shown in the past, and other financial ratios.

All these calculations and analyses determine the financial health of the company, historical business growth, company’s efficiency, and its stock price compared with real earnings (Corporate earnings reports India), which helps traders to make investment decisions for long-term investment strategies.

2. How to Use Our Tool

  • Search for the stock that you want to analyze in the search bar by typing the name of the company or ticker.
  • Once you land on the Stock Analytics Page, click on “Fundamental Analysis”; this will take you to the fundamental analysis page.
  • Apply Filter
  • On the “Fundamental Analysis” page, the first tab is for “Summary and Ratio,” where in the top section you can find the overall summary of the stock’s fundamental analysis, where on the leftmost side it has a textual summary, then in the middle a gauge chart that represents overall financial health, and then a list of important ratios.
  • Apply Filter
  • Then in the same “Summary and Ratio” tab, we have included a detailed analysis of stock in various aspects, which includes “Profitability Analysis,” “Liquidity Analysis,” “Efficiency Analysis,” “Coverage Analysis,” Solvency Analysis,” and “Market Analysis,” which divide the stock’s fundamentals into the above aspects and analyze each in the same format as for overall analysis, where the leftmost side has a textual summary, then in the middle a gauge chart that represents overall analysis of the particular section, and then a list of important ratios. Required for the particular analysis.
  • Apply Filter